
<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <title>Document Content</title>
    <style>
        body { line-height: 1.6; max-width: 900px; margin: auto; padding: 20px; background-color: #ffffff; }
        table { border-collapse: collapse; width: 100%; margin-top: 20px; margin-bottom: 20px; }
        th, td { border: 1px solid #cccccc; text-align: left; padding: 8px; }
        th { background-color: #f2f2f2; } /* Light gray background for headers */
        tr:nth-child(even) { background-color: #f9f9f9; }
        h2 { border-bottom: 2px solid #4F81BD; padding-bottom: 5px; }
        p { margin-block-start: 0.5em; margin-block-end: 0.5em; }
    </style>
</head>
<body>
    <p style="font-size: 12.0px; font-family: TimesNewRoman, serif; color: #000000">Page 38 of 119</p>
<p style="font-size: 10.0px; font-family: Helvetica, serif; color: #ff0000">Abbott_Laboratories_10k_038.pdf</p>
<p style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">The operating results of Abbott&#x27;s developed markets branded generics pharmaceuticals and animal health businesses, as well as the income tax benefit related to the businesses transferred to Abb Vie, which are being reported as discontinued operations are as follows:</p>

<table>
	<tr>
		<th style="font-size: 7.6px; font-family: TimesNewRoman,Bold, serif; color: #000000; font-weight: bold" rowspan="2">(in millions)</th>
		<th style="font-size: 7.6px; font-family: TimesNewRoman,Bold, serif; color: #000000; font-weight: bold" colspan="3">Year Ended December 31</th>
	</tr>
	<tr>
		<th style="font-size: 7.6px; font-family: TimesNewRoman,Bold, serif; color: #000000; font-weight: bold">2017</th>
		<th style="font-size: 7.6px; font-family: TimesNewRoman,Bold, serif; color: #000000; font-weight: bold">2016</th>
		<th style="font-size: 7.6px; font-family: TimesNewRoman,Bold, serif; color: #000000; font-weight: bold">2015</th>
	</tr>
	<tr>
		<td style="font-size: 10.0px; font-family: TimesNewRoman,Bold, serif; color: #000000; font-weight: bold">Net Sales</td>
		<td style="font-size: 12px; font-family: TimesNewRomanPSMT, serif; color: #000000"></td>
		<td style="font-size: 12px; font-family: TimesNewRomanPSMT, serif; color: #000000"></td>
		<td style="font-size: 12px; font-family: TimesNewRomanPSMT, serif; color: #000000"></td>
	</tr>
	<tr>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">Developed markets generics pharmaceuticals and animal health businesses</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">$ —</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">$ —</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">$ 256</td>
	</tr>
	<tr>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">Abb Vie</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">—</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">—</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">—</td>
	</tr>
	<tr>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">Total</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">$ —</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">$ —</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">$ 256</td>
	</tr>
	<tr>
		<td style="font-size: 10.0px; font-family: TimesNewRoman,Bold, serif; color: #000000; font-weight: bold">Earnings (Loss) Before Tax</td>
		<td style="font-size: 12px; font-family: TimesNewRomanPSMT, serif; color: #000000"></td>
		<td style="font-size: 12px; font-family: TimesNewRomanPSMT, serif; color: #000000"></td>
		<td style="font-size: 12px; font-family: TimesNewRomanPSMT, serif; color: #000000"></td>
	</tr>
	<tr>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">Developed markets generics pharmaceuticals and animal health businesses</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">$ 15</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">$ (4)</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">$ 13</td>
	</tr>
	<tr>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">AbbVie</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">—</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">—</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">—</td>
	</tr>
	<tr>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">Total</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">$ 15</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">$ (4)</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">$ 13</td>
	</tr>
	<tr>
		<td style="font-size: 10.0px; font-family: TimesNewRoman,Bold, serif; color: #000000; font-weight: bold">Net Earnings</td>
		<td style="font-size: 12px; font-family: TimesNewRomanPSMT, serif; color: #000000"></td>
		<td style="font-size: 12px; font-family: TimesNewRomanPSMT, serif; color: #000000"></td>
		<td style="font-size: 12px; font-family: TimesNewRomanPSMT, serif; color: #000000"></td>
	</tr>
	<tr>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">Developed markets generics pharmaceuticals and animal health businesses</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">$ 15</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">$ 3</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">$ 62</td>
	</tr>
	<tr>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">AbbVie</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">109</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">318</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">3</td>
	</tr>
	<tr>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">Total</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">$ 124</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">$ 321</td>
		<td style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">$ 65</td>
	</tr>
</table>
<h2 style="font-size: 10.0px; font-family: TimesNewRoman,Bold, serif; color: #000000; font-weight: bold">Assets and Liabilities Held for Disposition</h2>
<p style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">In September 2016, Abbott announced that it entered into a definitive agreement to sell Abbott Medical Optics (AMO), its vision care business, to Johnson &amp; Johnson for $4.325 billion in cash, subject to customary purchase price adjustments for cash, debt and working capital. The decision to sell AMO reflected Abbott&#x27;s proactive shaping of its portfolio in line with its strategic priorities. In February 2017, Abbott completed the sale of AMO to Johnson &amp; Johnson and recognized a pre- tax gain of $1.163 billion including working capital adjustments, which was reported in the Other (income) expense, net line of the Consolidated Statement of Earnings in 2017. Abbott recorded an after-tax gain of $728 million in 2017 related to the sale of AMO. The operating results of AMO up to the date of sale continued to be included in Earnings from continuing operations as the business did not qualify for reporting as discontinued operations. For 2017, 2016 and 2015, the AMO earnings (losses) before taxes included in Abbott&#x27;s consolidated earnings were $(18) million, $30 million and $64 million, respectively. Assets and liabilities of AMO were classified as held for disposition in Abbott&#x27;s Consolidated Balance Sheet as of December 31, 2016.</p>
<p style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">As discussed in the Business Acquisitions section, in conjunction with the acquisition of Alere, Abbott sold the Triage MeterPro cardiovascular and toxicology business and the assets and liabilities related to its B-type Natriuretic Peptide assay business run on Beckman Coulter analyzers to Quidel. The legal transfer of certain assets and liabilities related to these businesses did not occur at the close of the sale to Quidel due to, among other factors, the time required to transfer marketing authorizations and other regulatory requirements in various countries. Under the terms of the sale agreement with Abbott, Quidel is subject to the risks and entitled to the benefits generated by these operations and assets. The assets and liabilities presented as held for disposition in the Consolidated Balance Sheet as of December 31, 2017, primarily relate to the businesses sold to Quidel.</p>
<p style="font-size: 10.0px; font-family: TimesNewRoman, serif; color: #000000">37</p>
<p style="font-size: 12.0px; font-family: TimesNewRoman, serif; color: #000000">file://usmdcvdi003.us.kworld.kpmg.com/GDC_Ops/Operations/Gayathri%20Krishnan/RPA%20Phase%20II/Kiran/HealthCare/ ... 7/23/2018</p>

</body>
</html>
